EUVIMEDOpdag EUVIMED
Open access

Label-free, real-time monitoring of cytochrome C drug responses in microdissected tumor biopsies with a multi-well aptasensor platform

Tran N H Nguyen iD, Lisa F Horowitz iD, Timothy Krilov, Ethan Lockhart iD, Heidi L Kenerson, Taranjit S Gujral iD, Raymond S Yeung, Netzahualcóyotl Arroyo-Currás iD, Albert Folch iD

Science Advances · 2024-09-06 · 10 (36)

DOI: 10.1126/sciadv.adn5875 ↗

At a glance

Journal article in Science Advances, published on 2024-09-06. Written by Tran N H Nguyen and 8 co-authors. Institution: Department of Bioengineering, University of Washington, Seattle, WA 98105, USA. Major MEDLINE topics: Cytochromes c, Aptamers, Nucleotide. Cited 27 times so far (Crossref); 90 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Functional assays on intact tumor biopsies can complement genomics-based approaches for precision oncology, drug testing, and organs-on-chips cancer disease models by capturing key therapeutic response determinants, such as tissue architecture, tumor heterogeneity, and the tumor microenvironment. Most of these assays rely on fluorescent labeling, a semiquantitative method best suited for single-time-point assays or labor-intensive immunostaining analysis. Here, we report integrated aptamer electrochemical sensors for on-chip, real-time monitoring of cytochrome C, a cell death indicator, from intact microdissected tissues with high affinity and specificity. The platform features a multi-well sensor layout and a multiplexed electronic setup. The aptasensors measure increases in cytochrome C in the supernatant of mouse or human microdissected tumors after exposure to various drug treatments. Because of the sensor’s high affinity, it primarily tracks rising concentrations of cytochrome C, capturing dynamic changes during apoptosis. This approach could help develop more advanced cancer disease models and apply to other complex in vitro disease models, such as organs-on-chips and organoids.

Subjects

MeSH terms (MEDLINE)

Cytochromes cAptamers, NucleotideHumansAnimalsMiceNeoplasmsBiosensing TechniquesBiopsyCell Line, TumorApoptosisAntineoplastic Agents

Substances

Cytochromes cAptamers, NucleotideAntineoplastic Agents

Authors and institutions

  • Department of Bioengineering, University of Washington, Seattle, WA 98105, USA.
  • Department of Surgery, University of Washington, Seattle, WA 98105, USA.
  • Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98105, USA.
  • Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.

ORCID profiles: Tran N H Nguyen, Lisa F Horowitz, Ethan Lockhart, Taranjit S Gujral, Netzahualcóyotl Arroyo-Currás, Albert Folch

Funding

  • NCI NIH HHS

Cite

APA

Nguyen, T. N. H., Horowitz, L. F., Krilov, T., Lockhart, E., Kenerson, H. L., Gujral, T. S., Yeung, R. S., Arroyo-Currás, N., & Folch, A. (2024). Label-free, real-time monitoring of cytochrome C drug responses in microdissected tumor biopsies with a multi-well aptasensor platform. Science Advances, 10(36). https://doi.org/10.1126/sciadv.adn5875

Vancouver

Nguyen TNH, Horowitz LF, Krilov T, Lockhart E, Kenerson HL, Gujral TS, et al. Label-free, real-time monitoring of cytochrome C drug responses in microdissected tumor biopsies with a multi-well aptasensor platform. Science Advances. 2024;10(36). doi:10.1126/sciadv.adn5875

BibTeX
@article{Nguyen2024,
  author = {Nguyen, Tran N H and Horowitz, Lisa F and Krilov, Timothy and Lockhart, Ethan and Kenerson, Heidi L and Gujral, Taranjit S and Yeung, Raymond S and Arroyo-Currás, Netzahualcóyotl and Folch, Albert},
  title = {Label-free, real-time monitoring of cytochrome C drug responses in microdissected tumor biopsies with a multi-well aptasensor platform},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {36},
  doi = {10.1126/sciadv.adn5875}
}
Start for free →